Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Lung Tuberculosis
100%
Lung
78%
Prognostic Factor
77%
Computer Assisted Tomography
70%
Non Small Cell Lung Cancer
62%
Lung Cancer
57%
Hazard Ratio
53%
Odds Ratio
46%
Chronic Obstructive Pulmonary Disease
40%
Lung Adenocarcinoma
39%
Artificial Respiration
38%
Clinical Feature
32%
Silo-Filler's Disease
30%
Idiopathic Interstitial Pneumonia
29%
Tuberculosis
28%
Stenosis
26%
Elderly Patient
25%
Atypical Mycobacterium
24%
Asthma
24%
Body Mass Index
23%
Acute Respiratory Distress Syndrome
23%
Stenting
21%
Gefitinib
21%
Pulmonary Embolism
21%
Primary Tumor
21%
Retrospective Cohort Study
21%
Epidermal Growth Factor Receptor
21%
Dyspnea
20%
Influenza A (H1N1)
19%
Tuberculosis Treatment
19%
Levofloxacin
19%
Multidrug Resistant Tuberculosis
19%
Sputum
19%
Prevalence
18%
Lung Biopsy
18%
Patient Referral
17%
Thorax Radiography
17%
Erlotinib
16%
Medical Record
16%
Lung Nodule
16%
Forced Expiratory Volume
16%
Biopsy Technique
15%
Bronchoscopy
15%
Epidermal Growth Factor Receptor Kinase Inhibitor
15%
Low Drug Dose
15%
Transthoracic Biopsy
14%
Idiopathic Pulmonary Fibrosis
13%
Lung Lesion
13%
Coughing
13%
Sputum Culture
12%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Tuberculosis
47%
Non Small Cell Lung Cancer
38%
Chronic Obstructive Lung Disease
34%
Acute Respiratory Failure
29%
Lung Adenocarcinoma
29%
Gefitinib
26%
Erlotinib
21%
Epidermal Growth Factor Receptor
21%
Prevalence
20%
Levofloxacin
19%
Clinical Feature
17%
Lung Cancer
17%
Epidermal Growth Factor Receptor Kinase Inhibitor
16%
Asthma
16%
Community Acquired Pneumonia
14%
Hemoptysis
11%
Tuberculostatic Agent
10%
Tuberculosis
10%
Hospital Mortality
9%
Allergic Reaction
9%
Reflux Esophagitis
9%
Influenza A Virus (H1N1)
9%
Paclitaxel
9%
Small Cell Lung Cancer
9%
CYP2E1
9%
Spontaneous Pneumothorax
9%
Adult Respiratory Distress Syndrome
9%
Hepatotoxicity
9%
Topotecan
9%
Moxifloxacin
9%
Actinomycosis
9%
Multi-Drug-Resistant Tuberculosis
9%
Stenosis
9%
Lung Embolism
9%
Pranlukast
9%
Oseltamivir
9%
Dyspnea
8%
Overall Survival
8%
Progression Free Survival
7%
Interleukin 2
7%
Pneumonia
6%
Atelectasis
6%
Coughing
6%
Influenza A (H1N1)
6%
Pleura Effusion
5%
Afatinib
5%
Nursing and Health Professions
Confidence Interval
47%
Hazard Ratio
32%
Non Small Cell Lung Cancer
29%
Intensive Care Unit
24%
Obstructive Lung Disease
24%
Lung Cancer
22%
Odds Ratio
22%
Body Mass
21%
Elderly Patient
20%
Clinical Outcome
15%
Clinical Feature
15%
Artificial Respiration
14%
Tertiary Care Center
14%
Forced Expiratory Volume
12%
Acute Respiratory Failure
12%
Lung Tuberculosis
11%
Prevalence
11%
Long Term Care
9%
Grip Strength
9%
Fibrosing Alveolitis
9%
Femur Fracture
9%
Systolic Blood Pressure
9%
Acute Cholecystitis
9%
Lung Nodule
9%
Computer Assisted Tomography
8%
Hospital Mortality
7%
Proportional Hazards Model
7%
Cohort Analysis
6%
Multivariate Analysis
6%
Pneumonia
6%
Intensive Care
5%